Sanofi and Regeneron Announce Approval of Praluent alirocumab for the Treatment of Hypercholesterolemia in Japan Paris France and Tarrytown New York July 5 2016 Sanofi and Regeneron Pharmaceuticals Inc. announced today that the Ministry of Health Lab...
↧